IP Verse

Delivery Of Rna To Different Cell Types

Patent No. EP2591103 (titled "Delivery Of Rna To Different Cell Types") was filed by Glaxosmithkline on Jul 6, 2011. The application was issued on Aug 28, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SCHNAPPAUFMay 28, 2020-
JANSSEN VACCINES & PREVENTIONMay 27, 2020MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2591103

GLAXOSMITHKLINE
Application Number
EP11736498A
Filing Date
Jul 6, 2011
Status
Revoked
Mar 1, 2024
Publication Date
Aug 28, 2019
External Links
Slate, Register , Google Patents